
IDEXX Laboratories
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,216,585 | $1,140,820 | $1,090,579 | $1,105,239 |
Gross Profit | 779,087 | 722,739 | 658,114 | 683,354 |
EBITDA | 468,457 | 400,866 | 356,219 | 392,053 |
EBIT | 427,406 | 363,183 | 317,498 | 355,426 |
Net Income | 338,412 | 278,446 | 248,188 | 274,610 |
Net Change In Cash | 1,216,585 | 1,140,820 | 1,090,579 | 1,105,239 |
Free Cash Flow | 322,516 | 234,264 | 322,588 | 371,226 |
Cash | 196,933 | 200,528 | 180,070 | 208,166 |
Basic Shares | 80,675 | 80,675 | 80,675 | 80,675 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,303,702 | $3,897,504 | $3,660,953 | $3,367,324 |
Gross Profit | 2,659,579 | 2,378,927 | 2,189,970 | 2,004,338 |
EBITDA | 1,468,916 | 1,275,840 | 1,097,128 | 1,010,665 |
EBIT | 1,362,454 | 1,145,904 | 1,097,128 | 898,765 |
Net Income | 1,059,464 | 887,867 | 845,042 | 679,089 |
Net Change In Cash | 4,303,702 | 3,897,504 | 3,660,953 | 3,367,324 |
Cost of Revenue | -23,302 | |||
Free Cash Flow | 1,053,391 | 798,079 | 772,879 | 394,146 |
Cash | 180,070 | 288,266 | 453,932 | 112,546 |
Basic Shares | 80,675 | 83,056 | 83,978 | 84,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $4.27 |
2026-03-31 | $3.47 |
2025-12-31 | $3.08 |
2025-09-30 | $3.40 |